TY - JOUR
T1 - Autosomal recessive Noonan syndrome associated with biallelic LZTR1 variants
AU - Johnston, Jennifer J.
AU - van der Smagt, Jasper J.
AU - Rosenfeld, Jill A.
AU - Pagnamenta, Alistair T.
AU - Alswaid, Abdulrahman
AU - Baker, Eva H.
AU - Blair, Edward
AU - Borck, Guntram
AU - Brinkmann, Julia
AU - Craigen, William
AU - Dung, Vu Chi
AU - Emrick, Lisa
AU - Everman, David B.
AU - van Gassen, Koen L.
AU - Gulsuner, Suleyman
AU - Harr, Margaret H.
AU - Jain, Mahim
AU - Kuechler, Alma
AU - Leppig, Kathleen A.
AU - McDonald-McGinn, Donna M.
AU - Can, Ngoc Thi Bich
AU - Peleg, Amir
AU - Roeder, Elizabeth R.
AU - Rogers, R. Curtis
AU - Sagi-Dain, Lena
AU - Sapp, Julie C.
AU - Schäffer, Alejandro A.
AU - Schanze, Denny
AU - Stewart, Helen
AU - Taylor, Jenny C.
AU - Verbeek, Nienke E.
AU - Walkiewicz, Magdalena A.
AU - Zackai, Elaine H.
AU - Zweier, Christiane
AU - Zenker, Martin
AU - Lee, Brendan
AU - Biesecker, Leslie G.
N1 - Funding Information:
L.G.B., J.J.J., and J.C.S. received support from the Intramural Research Program of the National Human Genome Research Institute grants HG200328-11 and HG200388-03. A.A.S. received support from the Intramural Research Program of the
Funding Information:
National Library of Medicine. M.Z. received support from the German Federal Ministry of Education and Research (BMBF) NSEuroNet (FKZ 01GM1602A), GeNeRARe (FKZ 01GM1519A). J. A.R., W.C., L.E., M.J., and B.L. received support from the NIH Common Fund, through the Office of Strategic Coordination/ Office of the NIH Director under award number U01 HG007709-01. The High-Throughput Genomics Group at the Wellcome Centre for Human Genetics is funded by the Wellcome Trust (grant 090532/Z/09/Z). This work was also supported by the National Institute for Health Research (NIHR) Biomedical Research Centre Oxford with funding from the Department of Health’s NIHR Biomedical Research Centre’s funding scheme. The authors dedicate this paper to the children whose lives were claimed by this disease. We thank the families who supported this work and permitted us to share their information. The NIH authors thank Jean-Pierre Guadagnini for dental evaluations and Ms. Tasha Cantelmo and Ms. Kelly King for audiologic evaluations. The authors thank Christina Lissewski for molecular evaluation of families 7 and 8; Franziska Waldmann and Melanie Graf for clinical evaluation of family 8; Rebecca Okashah Littlejohn and James Gibson for evaluation of family 2; and Hugh Watkins, John Taylor, and the Oxford Regional Genetics Laborator for clinical evaluation and genetic studies in family 12. Jessica Chen provided the cDNA coordinates for the variants in the study by Chen et al.17 Tabitha Banks performed RT-PCR analyses on samples from families 1 and 3. Regional Genetics Laboratory 1. Julia Fekecs at NIH provided expert graphics support. The views expressed here are solely those of the authors and do not necessarily represent the views of the institutions the authors are funded by, or affiliated with.
Publisher Copyright:
© 2018, American College of Medical Genetics and Genomics.
PY - 2018/10/1
Y1 - 2018/10/1
N2 - Purpose: To characterize the molecular genetics of autosomal recessive Noonan syndrome. Methods: Families underwent phenotyping for features of Noonan syndrome in children and their parents. Two multiplex families underwent linkage analysis. Exome, genome, or multigene panel sequencing was used to identify variants. The molecular consequences of observed splice variants were evaluated by reverse-transcription polymerase chain reaction. Results: Twelve families with a total of 23 affected children with features of Noonan syndrome were evaluated. The phenotypic range included mildly affected patients, but it was lethal in some, with cardiac disease and leukemia. All of the parents were unaffected. Linkage analysis using a recessive model supported a candidate region in chromosome 22q11, which includes LZTR1, previously shown to harbor mutations in patients with Noonan syndrome inherited in a dominant pattern. Sequencing analyses of 21 live-born patients and a stillbirth identified biallelic pathogenic variants in LZTR1, including putative loss-of-function, missense, and canonical and noncanonical splicing variants in the affected children, with heterozygous, clinically unaffected parents and heterozygous or normal genotypes in unaffected siblings. Conclusion: These clinical and genetic data confirm the existence of a form of Noonan syndrome that is inherited in an autosomal recessive pattern and identify biallelic mutations in LZTR1.
AB - Purpose: To characterize the molecular genetics of autosomal recessive Noonan syndrome. Methods: Families underwent phenotyping for features of Noonan syndrome in children and their parents. Two multiplex families underwent linkage analysis. Exome, genome, or multigene panel sequencing was used to identify variants. The molecular consequences of observed splice variants were evaluated by reverse-transcription polymerase chain reaction. Results: Twelve families with a total of 23 affected children with features of Noonan syndrome were evaluated. The phenotypic range included mildly affected patients, but it was lethal in some, with cardiac disease and leukemia. All of the parents were unaffected. Linkage analysis using a recessive model supported a candidate region in chromosome 22q11, which includes LZTR1, previously shown to harbor mutations in patients with Noonan syndrome inherited in a dominant pattern. Sequencing analyses of 21 live-born patients and a stillbirth identified biallelic pathogenic variants in LZTR1, including putative loss-of-function, missense, and canonical and noncanonical splicing variants in the affected children, with heterozygous, clinically unaffected parents and heterozygous or normal genotypes in unaffected siblings. Conclusion: These clinical and genetic data confirm the existence of a form of Noonan syndrome that is inherited in an autosomal recessive pattern and identify biallelic mutations in LZTR1.
KW - autosomal recessive inheritance
KW - cardiomyopathy
KW - leukemia
KW - multiple congenital anomalies
KW - Noonan syndrome
UR - http://www.scopus.com/inward/record.url?scp=85054714726&partnerID=8YFLogxK
U2 - 10.1038/gim.2017.249
DO - 10.1038/gim.2017.249
M3 - Article
C2 - 29469822
SN - 1098-3600
VL - 20
SP - 1175
EP - 1185
JO - Genetics in Medicine
JF - Genetics in Medicine
IS - 10
ER -